#United States #New York #Securities Fraud #Rosen Law Firm #GeneDx Holdings

Rosen Law Firm Investigates GeneDx Holdings Corp for Securities Claims

In a recent development that has captured the attention of investors, the Rosen Law Firm, a globally recognized firm advocating for investor rights, has initiated an investigation into GeneDx Holdings Corp. (NASDAQ: WGS). The investigation is focused on potential claims regarding misleading business information that GeneDx may have shared with the public.

Background of the Investigation

The firm's inquiry comes in light of a critical report published on February 5, 2025, by Grizzly Research, which alleged that GeneDx is engaged in widespread fraudulent activities. According to Grizzly, the company’s reported growth is misleading, attributing this illusion to fraudulent practices aimed at exploiting healthcare funding systems such as Medicaid and Medicare to boost revenue artificially. Following the release of this report, GeneDx's stock experienced a significant decline, dropping by 6.7% on the same day.

The Rosen Law Firm wishes to inform anyone who purchased GeneDx securities that they may be entitled to compensation without incurring any out-of-pocket expenses, thanks to their contingency fee arrangement. The firm is diligently preparing to represent these investors in a class action lawsuit aimed at recovering their losses.

How to Participate in the Class Action

Investors eager to participate in this potential class action can easily sign up by visiting the Rosen Law Firm's official website at rosenlegal.com. Alternatively, they can reach out directly to Phillip Kim, Esq. via phone or email for further information about joining the case. The firm emphasizes the importance of acting swiftly, as legal timelines are often restrictive.

The Importance of Choosing the Right Legal Counsel

The Rosen Law Firm encourages investors to select legal representation with substantial experience in securities law and a strong track record of success. Notably, many firms that issue notices may lack the necessary resources, expertise, or reputation to handle complex securities class actions effectively. The Rosen Law Firm, on the other hand, has an impressive history, having achieved significant settlements in similar cases, including the largest settlement against a Chinese company at the time.

For multiple consecutive years, the firm has been recognized by ISS Securities Class Action Services as a leading firm in securities class action settlements. They have consistently ranked in the top tiers within the industry, securing hundreds of millions of dollars for investors. Just in 2019, the Rosen Law Firm successfully recovered over $438 million for affected investors.

The firm's founding partner, Laurence Rosen, has been acknowledged as a leading figure in the field of investor advocacy, earning accolades such as recognition from Law360 as a Titan of the Plaintiffs' Bar. Several attorneys within the firm have also been honored by reputable legal recognition platforms, reinforcing the firm's reputation as a premier choice for investor legal representation.

Conclusion

As the investigation into GeneDx Holdings progresses, the Rosen Law Firm remains committed to supporting the rights of shareholders and ensuring justice is served. Interested investors should consider engaging with the firm to explore their options for legal recourse.

For ongoing updates and information regarding this investigation, investors can follow the Rosen Law Firm on social media channels like LinkedIn, Twitter, and Facebook.

Attorney Advertising: It is important to note that prior results do not guarantee a similar outcome for all cases.

For further inquiries, contact:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Fax: (212) 202-3827
Email: [email protected]
Website: rosenlegal.com